Morning Market Movers (CRIS, OXPS, SMIT, TGE)
Curis Inc (NASDAQ: CRIS) shares surged 19.45% to $3.50 at 9:45 am. CRIS reported positive outcome in Genentech pivotal Phase II clinical trial of GDC-0449 in patients with advanced basal cell carcinoma (BCC).
Schmitt Industries Inc (NASDAQ: SMIT) climbed 14.94% to $4.00. SMIT had $3.21 million in total cash and no debt for the latest quarter.
Read more from Benzinga's Markets.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.